Your browser doesn't support javascript.
loading
Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.
Zinter, Matt S; Logan, Brent R; Fretham, Caitrin; Sapru, Anil; Abraham, Allistair; Aljurf, Mahmoud D; Arnold, Staci D; Artz, Andrew; Auletta, Jeffery J; Chhabra, Saurabh; Copelan, Edward; Duncan, Christine; Gale, Robert P; Guinan, Eva; Hematti, Peiman; Keating, Amy K; Marks, David I; Olsson, Richard; Savani, Bipin N; Ustun, Celalettin; Williams, Kirsten M; Pasquini, Marcelo C; Dvorak, Christopher C.
Affiliation
  • Zinter MS; Department of Pediatrics, Division of Critical Care Medicine, University of California, San Francisco, San Francisco, California. Electronic address: matt.zinter@ucsf.edu.
  • Logan BR; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA; Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.
  • Fretham C; Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA; National Marrow Donor Program, Minneapolis, MN, USA.
  • Sapru A; Department of Pediatrics, Division of Critical Care Medicine, University of California, Los Angeles, Los Angeles, California.
  • Abraham A; Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington DC, USA.
  • Aljurf MD; Department of Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Arnold SD; Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.
  • Artz A; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.
  • Auletta JJ; Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA.
  • Chhabra S; Division of Hematology/Oncology, Medical College of Wisconsin, Wisconsin, Milwaukee, WI, USA.
  • Copelan E; Blood and Marrow Transplantation Program, Arthur G. James Cancer Institute, Columbus, OH, USA.
  • Duncan C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gale RP; Department of Medicine, Division of Experimental Medicine, Hematology Research Centre, Imperial College London, London, United Kingdom.
  • Guinan E; Center for Clinical and Translational Research, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hematti P; University of Wisconsin, Madison, Wisconsin, Department of Medicine, Division of Hematology/Oncology.
  • Keating AK; Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Colorado School of Medicine, Colorado, Denver, CO, USA.
  • Marks DI; University Hospitals Bristol NHS Trust, Bristol, UK.
  • Olsson R; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institute, Solna, Sweden.
  • Savani BN; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Ustun C; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minnesota, Minneapolis, MN, USA.
  • Williams KM; Children's National Medical Center, The George Washington University Medical Center, Washington DC, USA.
  • Pasquini MC; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA; Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.
  • Dvorak CC; Department of Pediatrics, Division of Allergy, Immunology, and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, California.
Biol Blood Marrow Transplant ; 26(2): 333-342, 2020 02.
Article in En | MEDLINE | ID: mdl-31563573
ABSTRACT
Critically ill pediatric allogeneic hematopoietic cell transplant (HCT) patients may benefit from early and aggressive interventions aimed at reversing the progression of multiorgan dysfunction. Therefore, we evaluated 25 early risk factors for pediatric intensive care unit (PICU) mortality to improve mortality prognostication. We merged the Virtual Pediatric Systems and Center for International Blood and Marrow Transplant Research databases and analyzed 936 critically ill patients ≤21 years of age who had undergone allogeneic HCT and subsequently required PICU admission between January 1, 2009, and December 31, 2014. Of 1532 PICU admissions, the overall PICU mortality rate was 17.4% (95% confidence interval [CI], 15.6% to 19.4%) but was significantly higher for patients requiring mechanical ventilation (44.0%), renal replacement therapy (56.1%), or extracorporeal life support (77.8%). Mortality estimates increased significantly the longer that patients remained in the PICU. Of 25 HCT- and PICU-specific characteristics available at or near the time of PICU admission, moderate/severe pre-HCT renal injury, pre-HCT recipient cytomegalovirus seropositivity, <100-day interval between HCT and PICU admission, HCT for underlying acute myeloid leukemia, and greater admission organ dysfunction as approximated by the Pediatric Risk of Mortality 3 score were each independently associated with PICU mortality. A multivariable model using these components identified that patients in the top quartile of risk had 3 times greater mortality than other patients (35.1% versus 11.5%, P < .001, classification accuracy 75.2%; 95% CI, 73.0% to 77.4%). These data improve our working knowledge of the factors influencing the progression of critical illness in pediatric allogeneic HCT patients. Future investigation aimed at mitigating the effect of these risk factors is warranted.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Critical Illness / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Humans / Infant Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Critical Illness / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Humans / Infant Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2020 Type: Article